hydroxychloroquine has been researched along with niacinamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deleo, VA; Scheinfeld, N; Spann, CT; Tutrone, WD | 1 |
| BETTLEY, FR | 1 |
| Cardiel, MH; Codding, C; Garg, JP; Genovese, MC; Greenwald, M; Kivitz, AJ; Shay, K; Wang, A; Wang, X; Zubrzycka-Sienkiewicz, A | 1 |
1 review(s) available for hydroxychloroquine and niacinamide
| Article | Year |
|---|---|
Polymorphic light eruption.
Topics: Arachidonic Acid; Comorbidity; Dermatologic Agents; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Niacinamide; Photosensitivity Disorders; PUVA Therapy; Sunscreening Agents; Treatment Outcome | 2003 |
1 trial(s) available for hydroxychloroquine and niacinamide
| Article | Year |
|---|---|
Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease-Modifying Antirheumatic Drugs in the Treatment of Moderate-to-Severe Rheumatoid Arthritis.
Topics: Adamantane; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Janus Kinase 3; Male; Middle Aged; Niacinamide; Severity of Illness Index; Sulfasalazine; Treatment Outcome | 2017 |
1 other study(ies) available for hydroxychloroquine and niacinamide
| Article | Year |
|---|---|
CHILBLAIN LUPUS ERYTHEMATOSUS.
Topics: Chilblains; Chloroquine; Fluocinolone Acetonide; Frostbite; Humans; Hydroxychloroquine; Hypothyroidism; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Niacinamide; Quinacrine; Telangiectasis; Triamcinolone | 1964 |